Journal of Cancer

Ivyspring International Publisher

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Cancer is an open-access journal published by Ivyspring International Publisher in Australia, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 4,000 AUD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Ivyspring International Publisher
ISSN
1837-9664
Country
Australia
Languages
english
Access
Open access
Declared publication charge
4,000 AUD
Articles in DOAJ
162
Declared review time
12 weeks
Declared peer-review model
peer_review
Official website
http://www.jcancer.org

Index listings

  • DOAJ · 2010-05-31
  • PUBMED · 2010-06-01
Indexing
DOAJ · PUBMED
APC
4,000 AUD
Declared review time (DOAJ)
12 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

162

Most recent article

14 years ago

Average review time (journal-declared via DOAJ)

12weeks

Works in OpenAlex

5615

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

112

i10-index

3530

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2018-07-27
Added to DOAJ
2010-05-31
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMC
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101535920
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • RNA modifications and cancer
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
Show all subjects (50)
  • Circular RNAs in diseases
  • Circular RNAs in diseases
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • Cancer-related gene regulation
  • Cancer-related gene regulation
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Cancer Mechanisms and Therapy
  • Cancer Mechanisms and Therapy
  • Cancer Genomics and Diagnostics
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Genomics and Diagnostics
  • RNA Research and Splicing
  • RNA Research and Splicing
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Genetic factors in colorectal cancer
  • Head and Neck Cancer Studies
  • Genetic factors in colorectal cancer
  • Head and Neck Cancer Studies

Keywords (DOAJ)

  • medicine
  • cancer
  • oncology
  • cancer pathology
  • hematology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: